Long Term Culture of Mesenchymal Stem Cells: No Evidence of Chromosomal Instability

Authors

  • Hamid Zamani Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Fatemeh Karami Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahshid Mehdizadeh Department of Pediatric Hematology and Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Sedige Baakhlag Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mehdi Zamani Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Keywords:

Mesenchymal stem cell, culture, Chromosomal Instability, in-vivo

Abstract

Introduction: Mesenchymal stem cells (MSCs) technology has opened promising roads toward different aspects of medicine and biology. However, possible tumorgenic potential of MSCs has raised many concerns in using them in regenerative medicine. In the present study, we aimed to investigate the safety of MSCs by in-vitro culture and karyotype analysis.
Materials and Methods: MSCs were successfully cultured in DMEM medium including 3.5 ng/ml recombinant human basic fibroblast growth factor (bFGF) and 20 % fetal bovine serum (FBS) within 25 passages.
Results: No significant abnormality was observed in basic karyotype and morphology of MSCs in different passages of culture.
Conclusions: Using of EGF free medium containing low bFGF concentration are possible explanations for observed integrity in karyotype and morphology of MSCs. Our findings would be further convincing evidence on the safety of MSCs under suggested conditions to guarantee using of them in regenerative medicine and disease treatment.

Downloads

Published

2022-12-25

Issue

Vol. 7 No. 4 (2022)

Section

Research Articles/ Original Work

License

 West Asia Organization for Cabcer Prevention retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4 (This permits anyone to copy, distribute, transmit and adapt the published work, provided the original work and source are appropriately cited).